CP-547632

Item number	Size	Delivery time	Price
TGM-T10870L-1mg	1 mg	7 - 10 business days*	30.00€
TGM-T10870L-2mg	2 mg	7 - 10 business days*	41.00€
TGM-T10870L-5mg	5 mg	7 - 10 business days*	65.00€
TGM-T10870L-1mL	1 ml	7 - 10 business days*	76.00€
TGM-T10870L-10mg	10 mg	7 - 10 business days*	93.00€
TGM-T10870L-25mg	25 mg	7 - 10 business days*	169.00€
TGM-T10870L-50mg	50 mg	7 - 10 business days*	240.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of... more

Close menu

Product information "CP-547632"

Description: CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of VEGFR-2 and FGF kinase F with IC50s of 11 nM and 9 nM, respectively. CP-547632 is selective, with higher selectivity for VEGFR2 and bFGF than for EGFR, PDGFRbeta and related tyrosine kinases (TKs). PDGFRbeta and related tyrosine kinases (TKs) CP-547632 has antitumour activity. Target: FGFR, BTK, VEGFR, PDGFR. Smiles: NC(=O)c1c(NC(=O)NCCCCN2CCCC2)snc1OCc1c(F)cc(Br)cc1F. References: Beebe JS, et al. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Cancer Res. 2003 Nov 1 , 63(21):7301-9.

Supplier:	TargetMol
Supplier-Nr:	T10870L

Properties

MW:	532.4 D
Formula:	C20H24BrF2N5O3S

Database Information

CAS :

252003-65-9| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CP-547632"

Write a review